BECKI SUE HILL
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology CARLSBAD, NM NPI 1720059918
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology NM Amgen Inc. All categories
General Payments — all program years on this page
$184.72
- Category: General Payments
- Program years: PY2018–2019
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $131.26 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $131.26 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $85.28 | 5 |
| GENZYME CORPORATION | $19.24 | 1 |
| TAIHO ONCOLOGY, INC. | $15.34 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.40 | 1 |
By program year
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 662206175 | Amgen Inc. | $15.92 | 08/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662206177 | Amgen Inc. | $18.71 | 08/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662206179 | Amgen Inc. | $17.02 | 05/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662206181 | Amgen Inc. | $16.56 | 06/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662206183 | Amgen Inc. | $17.07 | 07/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 694072595 | GENZYME CORPORATION | $19.24 | 05/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697395755 | Takeda Pharmaceuticals U.S.A., Inc. | $11.40 | 08/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 708283899 | Taiho Oncology, Inc. | $15.34 | 08/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.